NASDAQ:GUTS
Fractyl Health, Inc.
Fractyl Health, Inc.'s revenue fell 100.0% in fiscal 2025 to $0. Free cash flow was −$90.9M, and the diluted share count rose 74.1%.Summary generated from Fractyl Health, Inc.'s SEC filings. Latest annual report filed Mar 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$0
Revenue growth−100.0%
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−744.2%
Debt / equityn/a
Free cash flow−$90.9M
FCF marginn/a
Share count change+74.1%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Operating income | −51 | −94 | −97 |
| Net income | −77 | −69 | −141 |
| Free cash flow | −43 | −67 | −91 |
Recent filings
- 8-KAmendment to articles or bylaws
Oct 1, 2026 - 8-KResults of a shareholder vote
Sep 24, 2026 - 4Insider transaction report
Sep 16, 2026 - 8-KNotice of delisting or listing-rule failure
Sep 11, 2026 - DEF 14AProxy statement
Aug 24, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 8-KRegulation FD disclosure
Jul 15, 2026